Carlos Jiménez to Neuroblastoma
This is a "connection" page, showing publications Carlos Jiménez has written about Neuroblastoma.
Connection Strength
1.041
-
Jim?nez C, Antonelli R, Nadal-Ribelles M, Devis-Jauregui L, Latorre P, Sol? C, Masanas M, Molero-Valenzuela A, Soriano A, S?nchez de Toledo J, Llobet-Navas D, Roma J, Posas F, de Nadal E, Gallego S, Moreno L, Segura MF. Structural disruption of BAF chromatin remodeller impairs neuroblastoma metastasis by reverting an invasiveness epigenomic program. Mol Cancer. 2022 09 03; 21(1):175.
Score: 0.702
-
Alvari?o R, Alfonso A, Pech-Puch D, Gegunde S, Rodr?guez J, Vieytes MR, Jim?nez C, Botana LM. Furanoditerpenes from Spongia (Spongia) tubulifera Display Mitochondrial-Mediated Neuroprotective Effects by Targeting Cyclophilin D. ACS Chem Neurosci. 2022 08 17; 13(16):2449-2463.
Score: 0.174
-
Masanas M, Masi? N, Su?rez-Cabrera L, Olivan M, Soriano A, Majem B, Devis-Jauregui L, Burgos-Panadero R, Jim?nez C, Rodriguez-Sodupe P, Boloix A, Toledano I, Guill?n G, Navarro A, Llobet-Navas D, Villanueva A, S?nchez de Toledo J, Roma J, Noguera R, Moreno L, Krauss R, Gallego S, Santamaria A, Segura MF. The oral KIF11 inhibitor 4SC-205 exhibits antitumor activity and potentiates standard and targeted therapies in primary and metastatic neuroblastoma models. Clin Transl Med. 2021 10; 11(10):e533.
Score: 0.165